Cargando…
Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide
Identifying drug resistance mutations is important for the clinical use of antivirals and can help define both a drug’s mechanism of action and the mechanistic basis of resistance. Resistance mutations are often identified one-at-a-time by studying viral evolution within treated patients or during v...
Autores principales: | Dingens, Adam S., Arenz, Dana, Overbaugh, Julie, Bloom, Jesse D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563210/ https://www.ncbi.nlm.nih.gov/pubmed/31096572 http://dx.doi.org/10.3390/v11050439 |
Ejemplares similares
-
Sphingopeptides: dihydrosphingosine‐based fusion inhibitors against wild‐type and enfuvirtide‐resistant HIV‐1
por: Ashkenazi, Avraham, et al.
Publicado: (2012) -
HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes
por: Matos, Pedro M., et al.
Publicado: (2010) -
Enfuvirtide−PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties
por: Cheng, Shuihong, et al.
Publicado: (2016) -
Identification of HIV-1 Envelope Mutations that Enhance Entry Using Macaque CD4 and CCR5
por: Roop, Jeremy I., et al.
Publicado: (2020) -
Mapping mutational effects along the evolutionary landscape of HIV envelope
por: Haddox, Hugh K, et al.
Publicado: (2018)